Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Memorial Sloan Kettering Cancer Center
Columbia University
Abramson Cancer Center at Penn Medicine
Peking University First Hospital
St. Jude Children's Research Hospital
University Hospital, Rouen
Asan Medical Center
Laikο General Hospital, Athens
Masonic Cancer Center, University of Minnesota
Peking Union Medical College Hospital
St. Jude Children's Research Hospital
The University of Texas Health Science Center at San Antonio
Central Hospital, Nancy, France
Nanjing First Hospital, Nanjing Medical University
Peking University First Hospital
AC Camargo Cancer Center
University of Wuerzburg
Fudan University
First Affiliated Hospital of Zhejiang University
University of Pennsylvania
Grupo Espanol de Tumores Neuroendocrinos
British Columbia Cancer Agency
Seoul National University Hospital
Cancer Research UK
Society for Endocrinology
Central Hospital, Nancy, France
University of Texas Southwestern Medical Center
Radboud University Medical Center
Peking Union Medical College Hospital
Fundación de investigación HM
University Medical Center Groningen
Mayo Clinic
Changi General Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Universidad Nacional Autonoma de Mexico
Northwell Health
King's College Hospital NHS Trust
University of Avignon
University Medical Center Groningen
Helsinki University Central Hospital
Seoul National University Hospital
Peking Union Medical College Hospital
Mayo Clinic
University of California, Los Angeles
Barts & The London NHS Trust
Yonsei University
University Hospital Olomouc
Peking Union Medical College Hospital
Children's Hospital Medical Center, Cincinnati